These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

867 related articles for article (PubMed ID: 36949304)

  • 1. Microbiota-Gut-Brain Axis: Pathophysiological Mechanism in Neuropsychiatric Disorders.
    Shin C; Kim YK
    Adv Exp Med Biol; 2023; 1411():17-37. PubMed ID: 36949304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments.
    Kim YK; Shin C
    Curr Neuropharmacol; 2018; 16(5):559-573. PubMed ID: 28925886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Human Gut Microbiome as a Potential Factor in Autism Spectrum Disorder.
    Alharthi A; Alhazmi S; Alburae N; Bahieldin A
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridging the Mind and Gut: Uncovering the Intricacies of Neurotransmitters, Neuropeptides, and their Influence on Neuropsychiatric Disorders.
    Gupta S; Dinesh S; Sharma S
    Cent Nerv Syst Agents Med Chem; 2024; 24(1):2-21. PubMed ID: 38265387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain.
    Deng Y; Zhou M; Wang J; Yao J; Yu J; Liu W; Wu L; Wang J; Gao R
    Gut Microbes; 2021; 13(1):1-16. PubMed ID: 33535879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
    Goyal D; Ali SA; Singh RK
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders.
    Socała K; Doboszewska U; Szopa A; Serefko A; Włodarczyk M; Zielińska A; Poleszak E; Fichna J; Wlaź P
    Pharmacol Res; 2021 Oct; 172():105840. PubMed ID: 34450312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics.
    Kim N; Yun M; Oh YJ; Choi HJ
    J Microbiol; 2018 Mar; 56(3):172-182. PubMed ID: 29492874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of microbiome changes and impact of probiotic supplementation in children and adolescents with neuropsychiatric disorders.
    Ligezka AN; Sonmez AI; Corral-Frias MP; Golebiowski R; Lynch B; Croarkin PE; Romanowicz M
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110187. PubMed ID: 33271210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric Ramifications of COVID-19: Short-Chain Fatty Acid Deficiency and Disturbance of Microbiota-Gut-Brain Axis Signaling.
    Sajdel-Sulkowska EM
    Biomed Res Int; 2021; 2021():7880448. PubMed ID: 34651049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between COVID-19 and the gut-brain axis: a gut feeling.
    Kalam N; Balasubramaniam VRMT
    Postgrad Med J; 2024 Jul; 100(1186):539-554. PubMed ID: 38493312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
    Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
    Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of the Human Microbiome in the Pathogenesis of Pain.
    Ustianowska K; Ustianowski Ł; Machaj F; Gorący A; Rosik J; Szostak B; Szostak J; Pawlik A
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Gut Dysbiosis in the Pathophysiology of Neuropsychiatric Disorders.
    Anand N; Gorantla VR; Chidambaram SB
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota- Brain-Gut-Axis Relevance to Parkinson's Disease: Potential Therapeutic Effects of Probiotics.
    Raj K; Singh S; Chib S; Mallan S
    Curr Pharm Des; 2022; 28(37):3049-3067. PubMed ID: 36200207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota and neuropsychiatric disorders: Implications for neuroendocrine-immune regulation.
    Ge T; Yao X; Zhao H; Yang W; Zou X; Peng F; Li B; Cui R
    Pharmacol Res; 2021 Nov; 173():105909. PubMed ID: 34543739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota alteration and modulation in psychiatric disorders: Current evidence on fecal microbiota transplantation.
    Settanni CR; Ianiro G; Bibbò S; Cammarota G; Gasbarrini A
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110258. PubMed ID: 33497754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota dysbiosis and Huntington's disease: Exploring the gut-brain axis and novel microbiota-based interventions.
    Sharma G; Biswas SS; Mishra J; Navik U; Kandimalla R; Reddy PH; Bhatti GK; Bhatti JS
    Life Sci; 2023 Sep; 328():121882. PubMed ID: 37356750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment.
    Liang Y; Cui L; Gao J; Zhu M; Zhang Y; Zhang HL
    Mol Neurobiol; 2021 Aug; 58(8):3745-3758. PubMed ID: 33825149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.